You are here: Industry Insights > > TUL was selected into Hang Seng index of "Shanghai, Shenzhen and Hong Kong innovative drug selection

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

TUL was selected into Hang Seng index of "Shanghai, Shenzhen and Hong Kong innovative drug selection

September 17, 2020

Tag:

Favorites

HSI announced earlier that the results of half year index review of Hang Seng Shanghai, Shenzhen and Hong Kong innovative drug selection 50 index as of April 30, 2020, including Livzon (01513), Genscript (01548), HANSOH Pharmaceutical (03692), TUL (03933), etc., while removing some of the original list of stocks, Hang Seng Shanghai Shenzhen Hong Kong innovative drug selection 50 index components remain unchanged. The change took effect on June 8.

Previous:Zhuhai United Laboratories Trading Company Limited was awarded "group member of the Second Council o

Next:TUL was awarded "Guangdong Province legal culture construction demonstration enterprise"

TUL was selected into Hang Seng index of "Shanghai, Shenzhen and Hong Kong innovative drug selection

You may like